GelMEDIX, Catalent Partner to Advance iPSC-Derived Cell Therapies

27Mar

GelMEDIX, Catalent Partner to Advance iPSC-Derived Cell Therapies

Portfolio News

GelMEDIX Inc., a biotechnology company developing regenerative therapies to restore vision, and Catalent Inc., a global contract development and manufacturing organization (CDMO), have partnered to utilize Catalent’s GMP-induced pluripotent stem cells (iPSC) and cell therapy manufacturing expertise and capabilities to support the development and clinical manufacturing of GelMEDIX’s iPSC-derived cell therapies to treat ocular and retinal diseases. Read More>>

Share this post

Related Posts

05Sep

Carbonite Names Executive Team

Newly appointed COO, CPO, CTO and Interim GC to accelerate Carbonite’s integration of Webroot. Results-driven leadership team to deliver on... read more
15Jun

MyoPro Powered Arm Brace Now Available for Teens with MS or Injuries, Myomo Announces

Myomo, a wearable medical robotics company, announced that MyoPro — its myoelectric orthosis or powered brace — is now available... read more
03Dec

The donation of sight

North Country Association for the Visually Impaired Executive Director Amy Kretser tries on a pair of Tina Leonard’s eSight glasses... read more
20Apr

Anonymous Donor Gives Man Gift of Sight with Electronic Eyewear Device

When Mike McIntyre was just nine months old, doctors found a brain tumor on his optic nerve and pituitary gland... read more
26Apr

EcoSoul Home Raises $10 Million, Plans To Expand To Newer Markets: Rahul Singh Exclusive | CNBC-TV18

 EcoSoul Home Inc is seeing a seismic shift in consumer interest towards sustainable products. It has raised $10 million in... read more
18Nov

Previously blind woman shares gift of sight with others

Britny can see thanks to special glasses called Esight. They help her focus and can make images 20 times larger.... read more
02Sep

The Race Is on for a ‘Concussion Pill’ as New NFL Season Begins

The "concussion pill" may be coming soon. "This is coming in 2025 if all goes well," Dr. William Korinek, the CEO of... read more
26Jun

NEO has played critical role in success of Boston-based medical device maker

When Boston-based medical device company Myomo rang the bell of the New York Stock Exchange on June 16, it was... read more
27Jan

Wasabi Technologies and Axis Communications Partner to Deliver Breakthrough Cloud Storage for Modern Video Surveillance

Wasabi Technologies, the hot cloud storage company, today announced that it has partnered with Axis Communications, the industry leader in... read more
18Oct

CytoAgents Announces Initiation of Patient Enrollment in Phase 1b/2a Clinical Trial to Treat Cytokine Release Syndrome in CAR T-cell Therapy

CytoAgents, Inc., a clinical-stage biotechnology company developing a safe, effective treatment for Cytokine Release Syndrome (CRS), today announced that it... read more